Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Full Text
Peer Reviewed
See detailLa prévention des rechutes adictives
Kempeneers, Philippe ULg

in Revue Francophone de Clinique Comportementale et Cognitive (1999), 4(4), 24-34

Relapse prevention (RP) is a model of therapeutic intervention started in the field of substance abuses but applicable to all addictive behaviors. This papper first specifies the concept of addiction ... [more ▼]

Relapse prevention (RP) is a model of therapeutic intervention started in the field of substance abuses but applicable to all addictive behaviors. This papper first specifies the concept of addiction. Follows a description of the principles of RP concerning the relapse process and a specification of RP as a clinical and theorical model. Finally there is a more detailed presentation of several mechansisms characteristics of addictive relapses as well as the modes of treatment the RP offers [less ▲]

Detailed reference viewed: 59 (5 ULg)
Full Text
See detailPrévention des risques liés à la metformine
Krzesinski, Jean-Marie ULg

Conference (2011, May 14)

La metformine est habituellement utilisée dans le traitement du diabète de type 2 avec obésité. Elle inhibe la lipogenèse, la néoglucogenèse et la glycogénolyse. Elle est aussi souvent prescrite au stade ... [more ▼]

La metformine est habituellement utilisée dans le traitement du diabète de type 2 avec obésité. Elle inhibe la lipogenèse, la néoglucogenèse et la glycogénolyse. Elle est aussi souvent prescrite au stade de l’intolérance au glucose ou dans l’hyperinsulinisme avec hypoglycémies réactionnelles. Ce médicament a une biodisponibilité orale de 50 à 60 %. Il n’a pas de métabolisation et sa fixation aux protéines plasmatiques est négligeable. Son élimination se fait inchangée dans les urines (90 %) avec une demi-vie plasmatique de ± 6 heures. [less ▲]

Detailed reference viewed: 45 (6 ULg)
See detailPrévention des troubles du langage & intervention précoce en logopédie . Que faire entre 0 et 5 ans ?
Maillart, Christelle ULg

Conference given outside the academic context (2010)

Detailed reference viewed: 250 (16 ULg)
See detailPrévention des troubles musculo-squelettiques chez le sportif
Julia, Marc; Croisier, Jean-Louis ULg; Perrey, S. et al

Book published by Sauramps Medical (2013)

Detailed reference viewed: 85 (21 ULg)
Full Text
Peer Reviewed
See detailPrevention du diabete de type 2: style de vie ou medicaments?
Scheen, André ULg; Letiexhe, Michel ULg; Ernest, Philippe ULg

in Revue Médicale de Liège (2003), 58(4), 206-10

The World Health Organisation strongly recommends strategies for the prevention of type 2 diabetes, knowing the epidemics of the disease and its strong association with that of obesity. Several ... [more ▼]

The World Health Organisation strongly recommends strategies for the prevention of type 2 diabetes, knowing the epidemics of the disease and its strong association with that of obesity. Several intervention studies, in China ("Da-Qing Study"), in Europe ("Malmo study", "Finnish Diabetes Prevention Study") and in the United States ("Diabetes Prevention Program"), showed that lifestyle change are able to reduce by around 50% the incidence of type 2 diabetes in at risk individuals. Various pharmacological approaches have also proven their efficacy in preventing type 2 diabetes, but in most cases with less impressive reductions, between 25% and 35%. It is the case for metformin, acarbose, orlistat or various inhibitors of the renin-angiotensin system. After the report of promising results with troglitazone, large prospective studies are ongoing to test the efficacy of rosiglitazone and pioglitazone in such an indication, two insulinsensitizers of the thiazolidinedione family. We will briefly described the main results of intervention studies to prevent type 2 diabetes in at risk subjects, because of the presence of obesity, impaired glucose tolerance and/or arterial hypertension. [less ▲]

Detailed reference viewed: 295 (3 ULg)
Full Text
Peer Reviewed
See detailPrevention du diabete de type 2: un nouveau defi de sante publique.
Scheen, André ULg; Giet, Didier ULg

in Revue Médicale de Liège (2005), 60(5-6), 383-90

Owing to the epidemics of type 2 diabetes, it is important to develop strategies of prevention of the disease. The first step should detect patients at risk, in function of simple anamnesis, clinical and ... [more ▼]

Owing to the epidemics of type 2 diabetes, it is important to develop strategies of prevention of the disease. The first step should detect patients at risk, in function of simple anamnesis, clinical and biological criteria. Afterwards, those individuals should be encouraged to follow a prevention programme, which essentially comprises better lifestyle habits (diet and physical exercise), especially to prevent or correct weight excess. In at very high risk subjects, for instance because of moderately increased fasting or post-glucose load glucose levels, eventually in a context of family history of type 2 diabetes, a pharmacological approach could be considered. Various drugs (metformin, acarbose, glitazones, orlistat, inhibitors of the renin-angiotensin system) have proven their efficacy in reducing the incidence of type 2 diabetes, in particular in individuals with impaired glucose tolerance, with obesity and/or with arterial hypertension. [less ▲]

Detailed reference viewed: 444 (2 ULg)
Full Text
Peer Reviewed
See detailPrevention du paludisme chez l'adulte
Leonard, Philippe ULg; Moutschen, Michel ULg; Demonty, Jean ULg

in Revue Médicale de Liège (2003), 58(6), 382-7

Great scourge of poor countries, malaria is the most important tropical parasitic disease. It is responsible for a large number of deaths in concerned countries and represents a real danger for travellers ... [more ▼]

Great scourge of poor countries, malaria is the most important tropical parasitic disease. It is responsible for a large number of deaths in concerned countries and represents a real danger for travellers going to endemic regions. So, prophylactic measures are essential. On the one hand protective measures against mosquito bites, by wearing covering clothes, by using repellents and bed net (eventually impregnated with insecticide) will be useful. On the other hand, chemoprophylaxis is most often necessary, adapted to the possibility of chloroquine resistant P. falciparum, to the length or conditions of travel, and to the traveller's antecedents and age. Special concern about pregnant woman is necessary, due to potential severity of malaria. Chemoprophylaxis needs to be continued after coming back, for a duration depending on the drug used. Unfortunately, no prophylaxis is 100% effective, and the appearance of fever during the travel or two to three months after return requires medical advice. In some circumstances, it is necessary to prescribe a stand-by emergency treatment, if no quick medical advice is possible. [less ▲]

Detailed reference viewed: 41 (5 ULg)
See detailPrévention et action en faveur de la paix
Kabamba, Bob ULg

Learning material (2006)

Detailed reference viewed: 4 (1 ULg)
See detailPrévention et Politiques publiques de sécurité
Lemaître, André ULg

Learning material (2008)

Detailed reference viewed: 82 (27 ULg)
See detailPrévention et Promotion de la Santé
Bruyère, Olivier ULg

Learning material (2000)

Detailed reference viewed: 14 (3 ULg)
Peer Reviewed
See detailPrévention et traitement de l'ostéoporose postménopausique
Reginster, Jean-Yves ULg; SARLET, Nathalie ULg

in Problèmes Pratiques de Rhumatologie (1989), 19

Detailed reference viewed: 3 (2 ULg)
Full Text
Peer Reviewed
See detailPrévention et traitement des nausées et vomissements après chimiothérapie anticancéreuse
Brasseur, Edmond ULg; Silvestre, Rose-Marie; Jerusalem, Guy ULg et al

in Médecine et Hygiène (2002), 60

Detailed reference viewed: 72 (6 ULg)
Full Text
See detailPrévention et traitement des radiodermites.
Henry, Frédérique ULg; Uhoda, Emmanuelle ULg; Pierard, Gérald ULg

in Skin (2008), 11

Les radiodermites sont variables tant par leur nature que par leur intensité. De nombreuses tentatives de prévention ou de traitement de ces effets cutanés indésirables ont été rapportées dans la ... [more ▼]

Les radiodermites sont variables tant par leur nature que par leur intensité. De nombreuses tentatives de prévention ou de traitement de ces effets cutanés indésirables ont été rapportées dans la littérature. Leur efficacité est variable et souvent infondée ou décevante. Une information du patient et une approche multidisciplinaire sont souhaitables pour la prise en charge des radiodermites. [less ▲]

Detailed reference viewed: 114 (4 ULg)
Full Text
Peer Reviewed
See detailLa prévention médicalisée est-elle néfaste pour nos patients ? Et à quelles conditions leur serait-elle bénéfique ?
Vanmeerbeek, Marc ULg

Conference (2009, June 25)

En examinant nos pratiques en prévention, il semble nécessaire de mieux asseoir la validité scientifique de nos actes, e.a. en prenant de la distance par rapport aux pressions commerciales. Il serait ... [more ▼]

En examinant nos pratiques en prévention, il semble nécessaire de mieux asseoir la validité scientifique de nos actes, e.a. en prenant de la distance par rapport aux pressions commerciales. Il serait utile de rapprocher la médecine générale et la santé publique, en augmentant la place de la promotion de la santé et ne développant la place du patient. De nouvelles tâches sont à imaginer dans un partenariat multidisciplinaire. [less ▲]

Detailed reference viewed: 23 (3 ULg)
Peer Reviewed
See detailPrevention of Aorta-Coronary Bypass Graft Occlusion. Beneficial Effect of Ticlopidine on Early and Late Patency Rates of Venous Coronary Bypass Grafts: A Double-Blind Study
Limet, Raymond ULg; David, Jean-Louis ULg; Magotteaux, Paul ULg et al

in Journal of Thoracic and Cardiovascular Surgery (The) (1987), 94(5), 773-83

The efficacy of coronary bypass grafting obviously being linked to graft patency, it is compulsory to look for any innovation that could improve the patency rate. Ticlopidine, an antiplatelet drug, was ... [more ▼]

The efficacy of coronary bypass grafting obviously being linked to graft patency, it is compulsory to look for any innovation that could improve the patency rate. Ticlopidine, an antiplatelet drug, was tested against placebo in a double-blind trial: 173 patients (475 grafts) subjected to venous coronary artery bypass grafting were randomly treated with ticlopidine (250 mg twice daily) or placebo from the second postoperative day for 12 months. Graft patency was assessed by digital angiography on days 10 (99.4% of the patients), 180 (98.2%), and 360 (91.7%). The effect of treatment on platelet aggregation and bleeding time were measured concomitantly; a clear-cut effect was demonstrated at each interval. Intention-to-treat graft-by-graft analysis shows that ticlopidine significantly reduced the graft occlusion rate on day 10 (7.1% versus 13.4%, p less than 0.05), day 180 (15.0% versus 24.0%, p less than 0.02), and day 360 (15.9% versus 26.1%, p less than 0.01). Sequential grafts to the left anterior descending coronary artery, with side-to-side anastomosis to diagonal branch(es), are less frequently occluded than individual grafts. On the contrary, grafts to endarterectomized vessels occlude more frequently. Individual patient-by-patient analysis shows that patency of all grafts at each study time, is more frequent in the ticlopidine group. The difference is significant when one considers patients without sequential or endarterectomized grafts. The difference is also present at each study time: day 10 (84.4% versus 66.7%, p less than 0.05), day 180 (74.4% versus 52.3%, p less than 0.05) and day 360 (75.0% versus 52.5%, p less than 0.05). Results are even more impressive if one excludes from analysis the four patients in the ticlopidine group in whom administration of the drug was delayed. This supports previous suggestions that early therapy is necessary. These results show that graft occlusion occurs mainly in the first 6 postoperative months. The incidence of occlusion is significantly reduced by ticlopidine therapy. [less ▲]

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailPrevention of bacterial biofilms by covalent immobilization of peptides onto plasma polymer functionalized substrates
Vreuls, Christelle ULg; Zocchi, Germaine ULg; Thierry, Benjamin et al

in Journal of Materials Chemistry (2010), 20

In this study, robust antibacterial coatings were created on stainless steel through the covalent grafting of antibacterial peptides onto an organic-polymeric interlayer deposited by RF-glow discharge ... [more ▼]

In this study, robust antibacterial coatings were created on stainless steel through the covalent grafting of antibacterial peptides onto an organic-polymeric interlayer deposited by RF-glow discharge plasma. X-Ray photoelectron spectroscopy was used to characterize and optimize the two steps of the coating process. The biocidal activity of these surfaces was demonstrated against both Gram+ and Gram- bacteria using ISO tests. 3 to 6 log10 reductions of both Gram+ and Gram- bacterial strains were obtained compared to uncoated stainless steel and depending on the particular antibacterial peptide immobilized. Importantly the antibacterial surfaces were resistant to several cleaning conditions. The latter is significant as the stability of such antibacterial surfaces in close to real life conditions is a major concern and leaching, de-lamination, rearrangement and ageing of the coating can lead to insufficient long term biofilm resistance of the surface. [less ▲]

Detailed reference viewed: 46 (9 ULg)